ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Oregon » Pulmonary Disease

Top Pulmonary Disease Prescribers in Oregon

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOHN SILVER M.D.

Pulmonary Disease

4,190

$580K

410
328 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 60%

$138
Average prescription price

Avg: $253

BINAYA RIMAL M.D.

Pulmonary Disease

2,226

$445K

327
242 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 60%

$200
Average prescription price

Avg: $253

JOHN BUTLER M.D.

Pulmonary Disease

2,165

$688K

322
271 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

72%
prescriptions for brand name drugs

Avg: 60%

$318
Average prescription price

Avg: $253

KHURAM AMEEN M.D.

Pulmonary Disease

2,109

$559K

252
206 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 60%

$265
Average prescription price

Avg: $253

JAMES PAROSA M.D.

Pulmonary Disease

2,091

$301K

164
141 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 60%

$144
Average prescription price

Avg: $253

RALPH JUAREZ M.D.

Pulmonary Disease

1,928

$314K

243
206 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 60%

$163
Average prescription price

Avg: $253

KAMALJIT ATWAL DO

Pulmonary Disease

1,909

$271K

198
150 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 60%

$142
Average prescription price

Avg: $253

KISHORE PATHIAL MD

Pulmonary Disease

1,805

$215K

401
335 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 60%

$119
Average prescription price

Avg: $253

JOSEPH SCHOENHALS MD

Pulmonary Disease

1,770

$450K

187
141 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 60%

$254
Average prescription price

Avg: $253

JOHN ORDAL MD

Pulmonary Disease

1,750

$438K

223
187 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 60%

$250
Average prescription price

Avg: $253

ANDREW URI MD

Pulmonary Disease

1,603

$270K

224
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 60%

$169
Average prescription price

Avg: $253

KAMAL SHAKER MD

Pulmonary Disease

1,547

$238K

201
167 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 60%

$154
Average prescription price

Avg: $253

MARTIN JOHNSON M.D.

Pulmonary Disease

1,540

$242K

237
161 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 60%

$157
Average prescription price

Avg: $253

ALPANA CHANDRA M.D.

Pulmonary Disease

1,448

$235K

211
156 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 60%

$162
Average prescription price

Avg: $253

JEFFREY BLUHM M.D.

Pulmonary Disease

1,394

$429K

205
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

74%
prescriptions for brand name drugs

Avg: 60%

$308
Average prescription price

Avg: $253

KAMRAN FIROOZI M.D.

Pulmonary Disease

1,389

$364K

192
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 60%

$262
Average prescription price

Avg: $253

INDULAL RUGHANI M.D.

Pulmonary Disease

1,375

$161K

220
193 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 60%

$117
Average prescription price

Avg: $253

KEVIN SHERER MD

Pulmonary Disease

1,350

$1.06M

184
140 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 60%

$785
Average prescription price

Avg: $253

GEORGE GIACOPPE MD

Pulmonary Disease

1,291

$157K

210
166 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 60%

$122
Average prescription price

Avg: $253

MATTHEW WALTER M.D.

Pulmonary Disease

1,202

$496K

146
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 60%

$412
Average prescription price

Avg: $253

JONATHAN RETTMANN M.D.

Pulmonary Disease

1,162

$618K

189
164 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 60%

$532
Average prescription price

Avg: $253

WAYNE STRAUSS MD, PHD

Pulmonary Disease

1,130

$729K

141
108 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 60%

$645
Average prescription price

Avg: $253

KARTHIK MAHADEVAN MD

Pulmonary Disease

1,116

$231K

198
138 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 60%

$207
Average prescription price

Avg: $253

RAZVAN GOSMAN MD

Pulmonary Disease

1,112

$195K

151
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 60%

$175
Average prescription price

Avg: $253

CARLOS MARCHINI MD

Pulmonary Disease

1,058

$220K

185
150 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 60%

$208
Average prescription price

Avg: $253

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank